Annovis Bio, Inc.

Annovis Bio is a drug development company working on treatments for brain diseases like Alzheimer's and Parkinson's. Their main drug candidate, Buntanetap, is in late-stage testing (phase 3) for Alzheimer's disease and is also being tested for Parkinson's disease. The company is also testing other drugs for traumatic brain injury, stroke, and cognitive decline in advanced dementia cases. All of these drugs are still in clinical trials and have not yet been approved by regulators.